All the major global stock markets ended the week in the red with Hong Kong (down 2.8%) and Brazil (down 4.4%) leading the pack of losers. The US stock market registered losses (down 1.2%) over the week on account of disappointing economic reports regarding wage growth and drop in consumer confidence. The government spending cuts that kicked in March 1 also weighed heavy on the markets. Going forward, the monetary policy decision by the Federal Open Market Committee will influence US stock markets.
The European stock markets also registered losses over the week, concerned by Mr. Ben Bernanke's comments on a potential tapering of quantitative easing and on account of reports of drop in employment in Euro area. The stock markets in France and Germany were down by 1.57% and 1.57% respectively over the week.
The major Asian stock markets also ended the week in the red influenced by the developments in the global economy and the currency markets. The stock markets in China lost 2.2% over the week on account of slow economic growth and as World Bank cut its outlook for global expansion. It was a volatile week for stock markets in Japan (down 1.5%). The stock markets in Japan saw wild movements on account of growing volatility in global stock, bond and currency markets.
Source: Yahoo Finance |
Barring oil and gas, all the sectoral indices ended in the red with consumer durables (down 10.7%), and metal (down 5.5%) indices witnessing the maximum losses.
Source: BSE |
In another key economic development, the government released the data on Index of Industrial Production (IIP) for the month of April as well as for the period April-March 2012-13. In April, IIP grew by a sluggish 2% YoY on the back of growths of 2.8% and 0.7% clocked by Manufacturing and Electricity sectors, respectively as compared to year-ago levels. In the manufacturing sector, only 13 out 22 industry groups posted growth during April. However, output of the mining sector fell by 3% YoY for the month. The cumulative growth in IIP for the period April-March 2012-13 was a mere 1.1% with Manufacturing and Electricity sectors registering aggregate growths of 1.2% and 4%, respectively. The mining sector output declined by 2.4% for the period April-March 2012-13.
Now let us move to some news from the corporate world. The engineering major, state-run Bharat Heavy Electricals (BHEL) is likely to spend about Rs 8.7 bn as one-time expenditure on the proposed amalgamation of Bharat Heavy Plate & Vessels (BHPV) with itself. There will be annual recurring expenses to the tune of Rs 750 m with regard to employee salaries. Further, an amount of Rs 2240 m will be spent towards liabilities arising out of legal cases and excise duty/ service tax and outstanding loans to BHEL worth over Rs 2340 m. This estimated cost will be funded through the internal accruals of BHEL.
Company | 7-Jun-13 | 14-Jun-13 | Change | 52-wk High/Low | ||
Top gainersduring the week (BSE-A Group) | ||||||
IPCA Labs | 603 | 647 | 7.3% | 670/309 | ||
Idea Cellular | 129 | 136 | 5.7% | 138/71 | ||
GSK Consumer | 5,481 | 5,702 | 4.0% | 6020/2179 | ||
Mahindra Satyam | 106 | 111 | 3.9% | 131/65 | ||
Reliance Industries | 785 | 814 | 3.7% | 955/671 | ||
Top losersduring the week (BSE-A Group) | ||||||
Apollo Tyres | 91 | 65 | -28.8% | 102/71 | ||
Opto Circuits | 29 | 22 | -21.6% | 166/68 | ||
MMTC Ltd | 218 | 171 | -21.3% | 890/536 | ||
Sun TV | 426 | 347 | -18.5% | 494/220 | ||
Titan Industries | 272 | 225 | -17.5% | 314/196 |
The pharma major Pfizer Inc has reached a US$2.15 bn settlement with Israel based Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries related to patent infringement on its acid-reflux drug Protonix. As per the terms of settlement, Teva and Sun Pharma will compensate Pfizer's subsidiary Wyeth and Takeda for the losses incurred when two companies launched 'at-risk' generic versions of Protonix prior to the January 2011 expiration of the patent for pantoprazole (the drug's active ingredient). The drug acts to reduce the secretion of stomach acids and is used to treat the effects of gastroesophageal reflux disease. As per the settlement terms, Teva will pay US$ 800 m in 2013 and the remaining US$ 800 m by October 2014, while Sun Pharma will make a full payment of US$ 550 m in 2013. Of the total, Pfizer will receive 64% of the settlement and its partner Japan's Takeda Pharmaceutical Co, will receive 36% or about US$774 m from the settlement.
In some news from the auto sector, car sales in May stood at 143,216 units as against 163,222 units in May 2012, a decline of 12% year-on-year (YoY). This is the seventh consecutive month when the Indian car market has witnessed a drop in sales. Amidst these worrying signs for the auto sector, carmakers have been resorting to production cuts. For instance, India's leading passenger vehicle manufacturer Maruti Suzuki had announced closure of all its five plants for eight days in June with the aim to cut down inventory at factories and dealerships as well as for periodic maintenance. It is feared that such production cuts will eventually lead to several job losses.
The global stock markets remained weak as uncertainty clouded the stimulus measures across the world. The Indian markets also ended the week in the red. Going forward, the key events to watch out for will be the monetary policy decision by the Federal Open Market Committee. Besides the movements in the global economy and markets, the Indian stock markets will be influenced by Reserve Bank of India's policy review.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Stimulus concerns drag global markets". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!